165 related articles for article (PubMed ID: 9438863)
21. Crystal structure of a cAMP-dependent protein kinase mutant at 1.26A: new insights into the catalytic mechanism.
Yang J; Ten Eyck LF; Xuong NH; Taylor SS
J Mol Biol; 2004 Feb; 336(2):473-87. PubMed ID: 14757059
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
[TBL] [Abstract][Full Text] [Related]
23. A historical overview of protein kinases and their targeted small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
[TBL] [Abstract][Full Text] [Related]
24. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
26. Serine-53 at the tip of the glycine-rich loop of cAMP-dependent protein kinase: role in catalysis, P-site specificity, and interaction with inhibitors.
Aimes RT; Hemmer W; Taylor SS
Biochemistry; 2000 Jul; 39(28):8325-32. PubMed ID: 10889042
[TBL] [Abstract][Full Text] [Related]
27. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
28. Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.
Shomin CD; Meyer SC; Ghosh I
Bioorg Med Chem; 2009 Sep; 17(17):6196-202. PubMed ID: 19674907
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity.
Breitenlechner C; Gassel M; Hidaka H; Kinzel V; Huber R; Engh RA; Bossemeyer D
Structure; 2003 Dec; 11(12):1595-607. PubMed ID: 14656443
[TBL] [Abstract][Full Text] [Related]
30. NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase.
Langer T; Vogtherr M; Elshorst B; Betz M; Schieborr U; Saxena K; Schwalbe H
Chembiochem; 2004 Nov; 5(11):1508-16. PubMed ID: 15481030
[TBL] [Abstract][Full Text] [Related]
31. The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention.
Engh RA; Bossemeyer D
Adv Enzyme Regul; 2001; 41():121-49. PubMed ID: 11384741
[No Abstract] [Full Text] [Related]
32. Crystal structure of the E230Q mutant of cAMP-dependent protein kinase reveals an unexpected apoenzyme conformation and an extended N-terminal A helix.
Wu J; Yang J; Kannan N; Madhusudan ; Xuong NH; Ten Eyck LF; Taylor SS
Protein Sci; 2005 Nov; 14(11):2871-9. PubMed ID: 16253959
[TBL] [Abstract][Full Text] [Related]
33. Insights into the phosphoryl transfer catalyzed by cAMP-dependent protein kinase: an X-ray crystallographic study of complexes with various metals and peptide substrate SP20.
Gerlits O; Waltman MJ; Taylor S; Langan P; Kovalevsky A
Biochemistry; 2013 May; 52(21):3721-7. PubMed ID: 23672593
[TBL] [Abstract][Full Text] [Related]
34. PKA: a portrait of protein kinase dynamics.
Taylor SS; Yang J; Wu J; Haste NM; Radzio-Andzelm E; Anand G
Biochim Biophys Acta; 2004 Mar; 1697(1-2):259-69. PubMed ID: 15023366
[TBL] [Abstract][Full Text] [Related]
35. Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411.
Furet P; Caravatti G; Lydon N; Priestle JP; Sowadski JM; Trinks U; Traxler P
J Comput Aided Mol Des; 1995 Dec; 9(6):465-72. PubMed ID: 8789188
[TBL] [Abstract][Full Text] [Related]
36. The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A.
Gassel M; Breitenlechner CB; König N; Huber R; Engh RA; Bossemeyer D
J Biol Chem; 2004 May; 279(22):23679-90. PubMed ID: 14996846
[TBL] [Abstract][Full Text] [Related]
37. Structure of the unliganded cAMP-dependent protein kinase catalytic subunit from Saccharomyces cerevisiae.
Mashhoon N; Carmel G; Pflugrath JW; Kuret J
Arch Biochem Biophys; 2001 Mar; 387(1):11-9. PubMed ID: 11368172
[TBL] [Abstract][Full Text] [Related]
38. Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.
Breitenlechner CB; Friebe WG; Brunet E; Werner G; Graul K; Thomas U; Künkele KP; Schäfer W; Gassel M; Bossemeyer D; Huber R; Engh RA; Masjost B
J Med Chem; 2005 Jan; 48(1):163-70. PubMed ID: 15634010
[TBL] [Abstract][Full Text] [Related]
39. Evidence for an internal entropy contribution to phosphoryl transfer: a study of domain closure, backbone flexibility, and the catalytic cycle of cAMP-dependent protein kinase.
Li F; Gangal M; Juliano C; Gorfain E; Taylor SS; Johnson DA
J Mol Biol; 2002 Jan; 315(3):459-69. PubMed ID: 11786025
[TBL] [Abstract][Full Text] [Related]
40. Mapping the Free Energy Landscape of PKA Inhibition and Activation: A Double-Conformational Selection Model for the Tandem cAMP-Binding Domains of PKA RIα.
Akimoto M; McNicholl ET; Ramkissoon A; Moleschi K; Taylor SS; Melacini G
PLoS Biol; 2015; 13(11):e1002305. PubMed ID: 26618408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
